174 related articles for article (PubMed ID: 20407212)
21. The crystal structure of a T cell receptor in complex with peptide and MHC class II.
Reinherz EL; Tan K; Tang L; Kern P; Liu J; Xiong Y; Hussey RE; Smolyar A; Hare B; Zhang R; Joachimiak A; Chang HC; Wagner G; Wang J
Science; 1999 Dec; 286(5446):1913-21. PubMed ID: 10583947
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Latek RR; Suri A; Petzold SJ; Nelson CA; Kanagawa O; Unanue ER; Fremont DH
Immunity; 2000 Jun; 12(6):699-710. PubMed ID: 10894169
[TBL] [Abstract][Full Text] [Related]
23. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
[TBL] [Abstract][Full Text] [Related]
24. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
25. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
Honey K; Forbush K; Jensen PE; Rudensky AY
J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
[TBL] [Abstract][Full Text] [Related]
26. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
27. The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library.
Gregori S; Bono E; Gallazzi F; Hammer J; Harrison LC; Adorini L
Int Immunol; 2000 Apr; 12(4):493-503. PubMed ID: 10744651
[TBL] [Abstract][Full Text] [Related]
28. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
29. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket.
Suri A; Vidavsky I; van der Drift K; Kanagawa O; Gross ML; Unanue ER
J Immunol; 2002 Feb; 168(3):1235-43. PubMed ID: 11801660
[TBL] [Abstract][Full Text] [Related]
30. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
31. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
32. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
[TBL] [Abstract][Full Text] [Related]
33. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
34. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
35. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
37. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of class II MHC allelic control of T cell responses.
Racioppi L; Ronchese F; Schwartz RH; Germain RN
J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
[TBL] [Abstract][Full Text] [Related]
39. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
40. Differential requirement of MHC class II molecules expressed on hematopoietic cells for positive selection of CD4+ thymocytes in TCR alpha beta and TCR beta transgenic mice.
Fukui Y; Yamamoto K; Koga T; Yamane K; Sasazuki T
Int Immunol; 1997 Sep; 9(9):1385-91. PubMed ID: 9310842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
